COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,198 Articles (22,713 medRxiv, 8,485 bioRxiv)

Most recent first Previous |  Page 962: Articles 9611-9620  | Next

How dangerous is omicron and how effective are vaccinations?
Nesteruk, I., Rodionov, O.
10.1101/2022.01.27.22269909 — Posted: 2022-01-28
Cardiovascular, respiratory and functional effects of tele-supervised home-based exercise training in individuals recovering from COVID-19 hospitalization: A randomized clinical trial
Amaral, V. T. d., Viana, A. A., Heubel, A. D., Linares, S. N., Martinelli, B., Witzler, P. H. C., Oliveira, G. Y. O. d., Zanini, G. d. S., Silva, A. B., Mendes, R. G., Ciolac, E. G.
10.1101/2022.01.24.22269745 — Posted: 2022-01-28
COVID-19 vaccine attitude and its predictors among people living with chronic health conditions in Ibadan, Nigeria
Ojewale, L. Y., Afolabi, R. F., Ogunniyi, A.
10.1101/2022.01.27.22269947 — Posted: 2022-01-28
Open science policies of medical and health sciences journals before and during the COVID-19 pandemic: a repeat cross-sectional study
Gardener, A. D., Hicks, E. J., Jacklin, C., Tan, G., Cashin, A. G., Lee, H., Nunan, D., Toomey, E. C., Richards, G. C.
10.1101/2022.01.26.22269868 — Posted: 2022-01-28
EPIDEMIOLOGICAL CHARACTERISTICS AND SEVERITY OF OMICRON VARIANT CASES IN THE APHP CRITICAL CARE UNITS; THE APHP REALITY RESEARCH GROUP
Vieillard-Baron, A., APHP Reality research group
10.1101/2022.01.25.22269839 — Posted: 2022-01-28
Immunogenicity of COVID-19 mRNA Vaccines in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
Helfgott, D. C., Racine-Brzostek, S., Short, K. J., Zhao, Z., Christos, P., Nino, I., Niu, T., Contreras, J., Ritchie, E. K., Desai, P., Samuel, M., Roboz, G. J.
10.1101/2022.01.26.22269932 — Posted: 2022-01-28
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads
Fall, A., Eldesouki, R., Sachithanandham, J., Morris, C. P., Norton, J., Gaston, D., Forman, M., Abdullah, O., Gallagher, N., Li, M., Swanson, N. J., Pekosz, A., Klein, E., Mostafa, H.
10.1101/2022.01.26.22269927 — Posted: 2022-01-28
Humoral immune response of patients infected by earlier lineages of SARS-CoV-2 neutralizes wild types of the most prevalent variants in Brazil
Pauvolid-Correa, A., Costa Caetano, B., Machado, A. B., Araujo Ferreira, M., Valente, N., Keren, T., Geraldo, K., Motta, F., Goncalves Veloso dos Santos, V., Grinsztejn, B., Mendonca Siqueira, M., Resende, P. C.
10.1101/2022.01.24.22269379 — Posted: 2022-01-28
Anatomy of Covid outbreak of vaccinated: An observational case-control study of Covid breakthrough infections in medical college students at Rural Medical College, India
Nillawar, A. N., Chavan, M. N., Gayatri, S., Patil, S., Deshpande, J., Yadav, A., Nakate, P.
10.1101/2022.01.27.22269902 — Posted: 2022-01-28
Impact of voluntary risk-mitigation behaviour on transmission of the Omicron SARS-CoV-2 variant in England
Brooks-Pollock, E., Northstone, K., Pellis, L., Scarabel, F., Thomas, A. C., Nixon, E. J., Matthews, D. A., Steves, C. J., Bower, V., Garcia, M.-P., Timpson, N. J., Danon, L.
10.1101/2022.01.26.22269540 — Posted: 2022-01-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).